 |
|
| IBOGAINE, 56
| |
| | |
|
|
Proceedings from the First International Conference
To order this title, and for more information, click here
By
Kenneth Alper, New York University, U.S.A.
Geoffrey A. Cordell, Natural Products Inc., Evanston, IL, USA
Included in series
The Alkaloids,
Description
This book presents the Proceedings from the First International Conference on Ibogaines, held in November of 1999 at New York University's
School of Medicine. In essence, it presents significant new data on neurobiological, clinical, sociocultural, and policy aspects of ibogaine.
Ibogaine is a natural product derived from the bark of the root of the African shrub Tabernathe iboga. It has a history of use as a
medicinal and ceremonial agent in West Central Africa, and has been alleged to be effective as a treatment for substance dependence.
The study of Ibogaine may shed light on the neurobiology of addiction and lead to the development of new medication for the treatment
of addiction.
Currently, there is lack of formal approval for the use of ibogaine, and the demand of the addicts themselves has led
to a distinctive unofficial network which has provided ibogaine treatment in non-medical settings. If critical safety concerns can be
adequately addressed, ibogaine may provide an inexpensive and practical treatment approach, well adapted to environments where resources
are severely limited and there is pressing need for clinical services for heroin addicts, such as Eastern Europe.
This is a paperback
edition of Volume 56 of The Alkaloids (ISBN: 0-12-469556-6) edited by Geoffrey A. Cordell, University of Illinois at Chicago, U.S.A.
Audience
Chemists, pharmacologists, and biochemists
Contents
Mechanisms of Action of Ibogaine: Relevance to Putative Therapeutic Effects and Development of a Safer Iboga Alkaloid Congener (Stanley
Glick, Isabelle Maisonneuve, Karen Szumlinski)
Ibogaine as a Glutamate Antagonist: Relevance to its Putative Antiaddictive Properties
(Phil Skolnick)
Drug Discrimination Studies with Ibogaine (Scott Helsley, Richard Rabin, J.C. Winter)
Changes in Gene Expression and
Signal Transduction Following Ibogaine Treatment (Emmanuel Onaivi, B. Emmanuel Akinshola, Syed Ali)
Characterization of Multiple Sites
of Action of Ibogaine (Henry Sershen, Audrey Hashim, Abel Lajtha)
Comparative Neuropharmacology of Ibogaine and Its O-Des Methyl Metabolite,
Noribogaine (Michael Baumann, John Pablo, Syed Ali, Richard Rothman, Deborah Mash)
Ibogaine in the Treatment of Heroin Withdrawal (Deborah
Mash, Craig Kovera, John Pablo, Rachel Tyndale, Frank Ervin, Jeffrey Kamlet, W. Lee Hearn)
Sigma Receptors and Iboga Alkaloids (Wayne
Bowen)
Ibogaine Neurotoxicity Assessment: Electrophysiological, Neurochemical, and Neurohistological Methods (Zbigniew Binienda, Andrew
Scallet, Larry Schmued, Syed Ali)
Modulation of the Effects of Rewarding Drugs by Ibogaine (Linda Parker, Shepard Siegel)
Anxiogenic
Action of Ibogaine (Piotr Popik, Magorzata Wrobel)
"Returning to the Path": The Use of Ibogaine in Equatorial African Ritual Context
and the Binding of Time, Space, and Social Relationships (James W. Fernandez, Renate Fernandez)
Contemporary History (Kenneth Alper,
Dana Beal, Charles Kaplan)
From the Roots Up: Ibogaine and Addict Self-Help (Geerte Frenken)
Case Studies of Ibogaine Treatment: Implications
for Patient Management Strategies (Howard Lotsof, Norma Alexander)
| Bibliographic details |
Paperback, 333 pages, publication date: SEP-2001
ISBN-13: 978-0-12-053206-3
ISBN-10: 0-12-053206-9
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 76
USD 125
EUR 89.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
095/945
Last update: 4 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company